ClinicalTrials.Veeva

Menu

tDCS(Transcranial Direct Current Stimulation) Efficacy in Bipolar Depression : RCT Study

Seoul National University logo

Seoul National University

Status

Unknown

Conditions

tDCS

Treatments

Device: SHAM
Device: ACTIVE

Study type

Interventional

Funder types

Other
Industry

Identifiers

NCT03974815
YB_ST_IIT1901

Details and patient eligibility

About

The purpose of this study is to determine whether transcranial direct current stimulation (tDCS) is effective and safe in the treatment Bipolar depression.

Randomized, double-blind Controlled Clinical Trial. Subjects Adults (between 19 and 65 years of age) with Bipolar depression who meet the inclusion criteria and who agree to participate in the study Will recruit from clinical referrals.

  • Active tDCS Anode - left DLPFC Cathode - right DLPFC Electric current is 2mA - Current is applied for 30 min
  • Sham tDCS Same assembly is used Current is applied for 1 min

Both groups 30~42 stimulation sessions on consecutive days.

Baseline(visit 1), 2 week(visit 2), 4 week(visit 3), 6 week(visit 4), and 12 week(visit 5) Check compliance with mobile application(MINDD-CONNECT) connections.

Full description

Assessment:

Depression rating scale: HAM-D(Hamiltion Depresiion Rating Scale), HAM-A(Hamilton Anxiety Rating Scale) Maniac rating scale: YMRS(Young Mania rating scale) CGI-BP(Clinical Global Impression-Bipolar) Q-LES-Q-SF(Quality of Life Enjoyment and Satisfaction Short form) Q-LES-Q-Q(Quality of Life Enjoyment and Satisfaction Questionnaire) qEEG(Quantitative Electroencephalography)

Check compliance with mobile application(MINDD-CONNECT) connections.

Enrollment

64 estimated patients

Sex

All

Ages

19 to 65 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Type I or Type II of bipolar disorder meets the current major depression diagnostic criteria in DSM-5
  • CGI Severity of lightness score ≥ 4 points
  • Taking mood stabilizers for at least four weeks before the day of screening

Exclusion criteria

  • A history of clinically significant internal neurological disorders or head injury

  • mental retardation or cognitive impairment that will affect to make a consent form.

  • Patients at risk of suicide that may require hospitalization as determined by clinicians

  • A person who is determined to be excluded for using tDCS medical device for other reason (e.g. metal plate is inserted on head, etc.)

  • A person who is determined to have problems with scalp deformation, inflammatory response or brain wave and attachment of direct current because of other dermatological problem

  • A woman who disagree with medically allowed contraception* until 24 weeks after the application of investigational device among woman subject who is possible to get pregnant

    * Medically allowed contraception: condom, oral contraception for at least 3 month, injection or insert contraception, Intrauterine Device, etc.

  • pregnant woman or lactating woman

  • A person who is not suitable for this clinical trial based on principal investigator's determination other than above reasons

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Quadruple Blind

64 participants in 2 patient groups

ACTIVE
Experimental group
Description:
Active stimulation (tDCS) will be used in the dose of 2mA /30 min per day, for 6weeks. (minimum 5 times per week)(total of 30\~42 sessions)
Treatment:
Device: ACTIVE
SHAM
Sham Comparator group
Description:
Sham stimulation (tDCS) will be used in the dose of 0mA /30 min per day, for 6weeks. (minimum 5 times per week)(total of 30\~42 sessions)
Treatment:
Device: SHAM

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems